- Home
- IKT vs TYGO Comparison
IKT vs TYGO Comparison
Compare IKT & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IKT | TYGO |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.1M | 281.4M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IKT | TYGO |
|---|---|---|
| Price | $1.71 | $3.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $5.00 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 1.2M | 420.8K |
| Earning Date | 03-26-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.76 | ★ 97.12 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $103,536,000.00 |
| Revenue This Year | N/A | $30.78 |
| Revenue Next Year | $33.33 | $21.68 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 91.68 |
| 52 Week Low | $1.33 | $0.73 |
| 52 Week High | $2.37 | $4.57 |
Technical Indicators
Market Signals| Indicator | IKT | TYGO |
|---|---|---|
| Relative Strength Index (RSI) | 44.65 | 51.63 |
| Support Level | $1.43 | $3.24 |
| Resistance Level | $1.74 | $3.87 |
| Average True Range (ATR) | 0.10 | 0.32 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 50.00 | 37.25 |
Price Performance
Historical ComparisonAbout IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.